A role for the VLA-4 integrin in the activation of human memory B cells

被引:23
|
作者
Silvy, A
Altevogt, P
Mondiere, P
Bella, C
Defrance, T
机构
[1] INSERM U404,F-69365 LYON 07,FRANCE
[2] GERMAN CANC RES CTR,TUMOR IMMUNOL PROGRAM 0710,D-6900 HEIDELBERG,GERMANY
关键词
VLA-4; memory B cell; integrin;
D O I
10.1002/eji.1830271103
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is generally recognized that activation through membrane effector molecules such as CD40 or the B cell receptor (BCR) is mandatory to allow B cells to proliferate and differentiate into antibody (Ab)-secreting cells in response to cytokines. We show here that purified tonsillar B cells can be stimulated directly by a cytokine combination to proliferate and secrete immunoglobulins when cultures are performed at high cell density. The contact-mediated activation of B cells in this experimental system is strongly inhibited both by anti-very late antigen (VLA)-4 monoclonal Ab and by a peptide containing the LDV sequence specifically recognized by the alpha 4 integrin binding site. These reagents also significantly suppressed the B cell responses elicited by engagement of the BCR or CD40. Our data reveal that memory B cells but not virgin or germinal center B cells are sensitive to the direct stimulatory effect of cytokines in high-density cultures. Finally, we found that the dual expression of the alpha and beta chains of VLA-4 is a distinctive feature of the memory B cell population. Collectively, our findings support the notion that VLA-4-dependent homotypic B cell interactions can mediate a co-stimulatory signal to human memory B cells and might participate in the B cell activation triggered through the BCR and CD40.
引用
收藏
页码:2757 / 2764
页数:8
相关论文
共 50 条
  • [1] The integrin VLA-4 is vital for the engraftment of human PRE-B all cells in immunodeficient mice
    Filshie, RJA
    Gottlieb, DJ
    Bradstock, KF
    BLOOD, 1996, 88 (10) : 2132 - 2132
  • [2] EVIDENCE FOR A ROLE OF THE INTEGRIN VLA-4 IN LYMPHO-HEMATOPOIESIS
    MIYAKE, K
    WEISSMAN, IL
    GREENBERGER, JS
    KINCADE, PW
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03): : 599 - 607
  • [3] Imidazopyridines as VLA-4 integrin antagonists
    Phillips, David J.
    Davenport, Richard J.
    Demaude, Thierry A.
    Galleway, Fiona P.
    Jones, Mark W.
    Knerr, Laurent
    Perry, Benjamin G.
    Ratcliffe, Andrew J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 4146 - 4149
  • [4] The role of the VLA-4 integrin in adhesion and survival of chronic lymphocytic leukemia (CLL) cells
    Sahakyan, K.
    Hofbauer, S.
    Brachtl, G.
    Girbl, T.
    Henschler, R.
    Greil, R.
    Hartmann, T. N.
    ONKOLOGIE, 2010, 33 : 201 - 201
  • [5] VLA-4 antibody down regulates VLA-4 expression on stimulated human T cells
    Blake, JT
    Shah, K
    Matheravidathu, S
    Koo, GC
    FASEB JOURNAL, 2000, 14 (06): : A1141 - A1141
  • [6] Binding between heparin and the integrin VLA-4
    Schlesinger, Martin
    Simonis, Dirk
    Schmitz, Patrick
    Fritzsche, Juliane
    Bendas, Gerd
    THROMBOSIS AND HAEMOSTASIS, 2009, 102 (05) : 816 - 822
  • [7] Dehydrophenylalanine derivatives as VLA-4 integrin antagonists
    Porter, JR
    Archibald, SC
    Brown, JA
    Childs, K
    Critchley, D
    Head, JC
    Parton, TAH
    Robinson, MK
    Shock, A
    Taylor, RJ
    Warrellow, GJ
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (05) : 805 - 808
  • [8] THE ROLE OF THE VLA-4 INTEGRIN IN A MODEL OF AIRWAY INFLAMMATION IN THE GUINEA-PIG
    MILNE, AAY
    PIPER, PJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 : U43 - U43
  • [9] Activation status and function of the VLA-4 (alpha 4 beta 1) integrin expressed on human melanoma cell lines
    Saini, A
    Seller, Z
    Davies, D
    Marshall, JF
    Hart, IR
    INTERNATIONAL JOURNAL OF CANCER, 1997, 73 (02) : 264 - 270
  • [10] Squaric acid derivatives as VLA-4 integrin antagonists
    Porter, JR
    Archibald, SC
    Childs, K
    Critchley, D
    Head, JC
    Linsley, JM
    Parton, TAH
    Robinson, MK
    Shock, A
    Taylor, RJ
    Warrellow, GJ
    Alexander, RP
    Langham, B
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (07) : 1051 - 1054